Anne-Mieke Vandamme
AuthID: R-000-Q27
281
TITLE: A combination of poor adherence and a low baseline susceptibility score is highly predictive for HAART failure
AUTHORS: Van Vaerenbergh, K; De Geest, S; Derdelinckx, I; Bobbaers, H; Carbonez, A; Deschamps, A; De Graeve, V; De Saar, V; Ceunen, H; De Smet, K; Maes, B; Peetermans, W; Schrooten, Y; Desmyter, J; De Clercq, E; Van Ranst, M; Van Wijngaerden, E; Vandamme, AM;
PUBLISHED: 2002, SOURCE: Antiviral Chemistry and Chemotherapy, VOLUME: 13, ISSUE: 4
AUTHORS: Van Vaerenbergh, K; De Geest, S; Derdelinckx, I; Bobbaers, H; Carbonez, A; Deschamps, A; De Graeve, V; De Saar, V; Ceunen, H; De Smet, K; Maes, B; Peetermans, W; Schrooten, Y; Desmyter, J; De Clercq, E; Van Ranst, M; Van Wijngaerden, E; Vandamme, AM;
PUBLISHED: 2002, SOURCE: Antiviral Chemistry and Chemotherapy, VOLUME: 13, ISSUE: 4
INDEXED IN: 
Scopus
Scopus IN MY: 
ORCID
ORCID282
TITLE: env chimeric virus technology for evaluating human immunodeficiency virus susceptibility to entry inhibitors
AUTHORS: Fikkert, V; Cherepanov, P; van Laethem, K; Hantson, A; Van Remoortel, B; Pannecouque, C; De Clercq, E; Debyser, Z; Vandamme, AM; Witvrouw, M;
PUBLISHED: 2002, SOURCE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 46, ISSUE: 12
AUTHORS: Fikkert, V; Cherepanov, P; van Laethem, K; Hantson, A; Van Remoortel, B; Pannecouque, C; De Clercq, E; Debyser, Z; Vandamme, AM; Witvrouw, M;
PUBLISHED: 2002, SOURCE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 46, ISSUE: 12
IN MY: ORCID | 
ResearcherID
ORCID | ResearcherID283
TITLE: Preface - Virus evolution and molecular epidemiology Full Text
AUTHORS: Vandamme, AM;
PUBLISHED: 2002, SOURCE: VIRUS RESEARCH, VOLUME: 85, ISSUE: 1
AUTHORS: Vandamme, AM;
PUBLISHED: 2002, SOURCE: VIRUS RESEARCH, VOLUME: 85, ISSUE: 1
IN MY: ORCID | ResearcherID
ORCID | ResearcherID284
TITLE: Phylogenetic classification of TT virus groups based on the N22 region is unreliable Full Text
AUTHORS: Lemey, P; Salemi, M; Bassit, L; Vandamme, AM;
PUBLISHED: 2002, SOURCE: VIRUS RESEARCH, VOLUME: 85, ISSUE: 1
AUTHORS: Lemey, P; Salemi, M; Bassit, L; Vandamme, AM;
PUBLISHED: 2002, SOURCE: VIRUS RESEARCH, VOLUME: 85, ISSUE: 1
IN MY: ORCID | ResearcherID
ORCID | ResearcherID285
TITLE: Prevalence and origin of HIV-1 group M subtypes among patients attending a Belgian hospital in 1999 Full Text
AUTHORS: Snoeck, J; Van Dooren, S; Van Laethem, K; Derdelinckx, I; Van Wijngaerden, E; De Clercq, E; Vandamme, AM;
PUBLISHED: 2002, SOURCE: VIRUS RESEARCH, VOLUME: 85, ISSUE: 1
AUTHORS: Snoeck, J; Van Dooren, S; Van Laethem, K; Derdelinckx, I; Van Wijngaerden, E; De Clercq, E; Vandamme, AM;
PUBLISHED: 2002, SOURCE: VIRUS RESEARCH, VOLUME: 85, ISSUE: 1
IN MY: ORCID | ResearcherID
ORCID | ResearcherID286
TITLE: A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export
AUTHORS: Daelemans, D; Afonina, E; Nilsson, J; Werner, G; Kjems, J; De Clercq, E; Pavlakis, GN; Vandamme, AM;
PUBLISHED: 2002, SOURCE: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, VOLUME: 99, ISSUE: 22
AUTHORS: Daelemans, D; Afonina, E; Nilsson, J; Werner, G; Kjems, J; De Clercq, E; Pavlakis, GN; Vandamme, AM;
PUBLISHED: 2002, SOURCE: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, VOLUME: 99, ISSUE: 22
IN MY: ORCID | ResearcherID
ORCID | ResearcherID287
TITLE: The drug resistance profile of tenofovir: a story of resistance and resensitization
AUTHORS: Wolf, K; Walter, H; Schnell, T; Keulen, W; Beerenwinkel, N; Selbig, J; Vandamme, AM; Korn, K; Schmidt, B;
PUBLISHED: 2002, SOURCE: ANTIVIRAL THERAPY, VOLUME: 7
AUTHORS: Wolf, K; Walter, H; Schnell, T; Keulen, W; Beerenwinkel, N; Selbig, J; Vandamme, AM; Korn, K; Schmidt, B;
PUBLISHED: 2002, SOURCE: ANTIVIRAL THERAPY, VOLUME: 7
INDEXED IN: WOS
WOS IN MY: ORCID | ResearcherID
ORCID | ResearcherID288
TITLE: Determination of the optimal cut-offs for predicting the phenotype of nine different HIV drug-resistance algorithms
AUTHORS: Zeitler, N; Schmidt, B; Korn, K; Keulen, W; Boucher, CAB; Beerenwinkel, N; Selbig, J; Vandamme, AM; Winslow, DL; Shafer, R; Schapiro, JM; Boulme, R; Schmit, JC; Walter, H;
PUBLISHED: 2002, SOURCE: ANTIVIRAL THERAPY, VOLUME: 7
AUTHORS: Zeitler, N; Schmidt, B; Korn, K; Keulen, W; Boucher, CAB; Beerenwinkel, N; Selbig, J; Vandamme, AM; Winslow, DL; Shafer, R; Schapiro, JM; Boulme, R; Schmit, JC; Walter, H;
PUBLISHED: 2002, SOURCE: ANTIVIRAL THERAPY, VOLUME: 7
INDEXED IN: WOS
WOS IN MY: ORCID | ResearcherID
ORCID | ResearcherID289
TITLE: Drug resistance among therapy-naive HIV-infected patients studied by sequencing and VERSANT (TM) HIV-1 resistance assays (LiPA) has limited impact on treatment response.
AUTHORS: Derdelinckx, I; Van Laethem, K; Maes, B; Schrooten, Y; Dewit, S; Florence, E; Fransen, K; Ribas, SG; Marissens, D; Moutschen, M; Van Wijngaerden, E; Vaira, D; Zissis, G; Van Ranst, M; Vandamme, AM;
PUBLISHED: 2002, SOURCE: ANTIVIRAL THERAPY, VOLUME: 7
AUTHORS: Derdelinckx, I; Van Laethem, K; Maes, B; Schrooten, Y; Dewit, S; Florence, E; Fransen, K; Ribas, SG; Marissens, D; Moutschen, M; Van Wijngaerden, E; Vaira, D; Zissis, G; Van Ranst, M; Vandamme, AM;
PUBLISHED: 2002, SOURCE: ANTIVIRAL THERAPY, VOLUME: 7
INDEXED IN: WOS
WOS IN MY: ORCID | ResearcherID
ORCID | ResearcherID290
TITLE: Influence of subtype and treatment on genetic profiles of HIV-1 reverse transcriptase and protease: do they act independently in predicting position-specific mutation probabilities in non-subtype B sequences?
AUTHORS: Kantor, R; Katzenstein, D; Gonzales, M; Sirivichayakul, S; Cane, P; Pillay, C; Snoeck, J; Grossman, Z; Vandamme, AM; Morris, L; Pillay, D; Phanuphak, P; Schapiro, JM; Shafer, RW;
PUBLISHED: 2002, SOURCE: ANTIVIRAL THERAPY, VOLUME: 7
AUTHORS: Kantor, R; Katzenstein, D; Gonzales, M; Sirivichayakul, S; Cane, P; Pillay, C; Snoeck, J; Grossman, Z; Vandamme, AM; Morris, L; Pillay, D; Phanuphak, P; Schapiro, JM; Shafer, RW;
PUBLISHED: 2002, SOURCE: ANTIVIRAL THERAPY, VOLUME: 7
INDEXED IN: WOS
WOS IN MY: ORCID | ResearcherID
ORCID | ResearcherID